{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:31:23Z","timestamp":1758817883906,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["F. No. 5\/4\/6\/3\/OPH\/2019-NCD-II"],"award-info":[{"award-number":["F. No. 5\/4\/6\/3\/OPH\/2019-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-022-00808-z","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T08:04:23Z","timestamp":1666685063000},"page":"342-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients"],"prefix":"10.1007","volume":"36","author":[{"given":"Nikhil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithalesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lata","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neiwete","family":"Lomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Meel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Pushker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-9017","authenticated-orcid":false,"given":"Seema","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"1","key":"808_CR1","doi-asserted-by":"publisher","first-page":"18594","DOI":"10.1038\/s41598-021-98084-8","volume":"11","author":"WS Lee","year":"2021","unstructured":"Lee WS, Lee J, Choi JJ, Kang HG, Lee SC, Kim JH. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients. Sci Rep. 2021;11(1):18594. https:\/\/doi.org\/10.1038\/s41598-021-98084-8.","journal-title":"Sci Rep"},{"issue":"6","key":"808_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3892\/etm.2021.10863","volume":"22","author":"DC Branisteanu","year":"2021","unstructured":"Branisteanu DC, Bogdanici CM, Branisteanu DE, Maranduca MA, Zemba M, Balta F, et al. Uveal melanoma diagnosis and current treatment options (Review). Exp Ther Med. 2021;22(6):1428. https:\/\/doi.org\/10.3892\/etm.2021.10863.","journal-title":"Exp Ther Med"},{"issue":"1","key":"808_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24. https:\/\/doi.org\/10.1038\/s41572-020-0158-0.","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"808_CR4","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.Can-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205\u20139. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-1750.","journal-title":"Cancer Res"},{"key":"808_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-62703-727-3_22","volume":"1102","author":"JW Harbour","year":"2014","unstructured":"Harbour JW. A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol Biol. 2014;1102:427\u201340. https:\/\/doi.org\/10.1007\/978-1-62703-727-3_22.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"808_CR6","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","volume":"98","author":"TH van Essen","year":"2014","unstructured":"van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol. 2014;98(12):1738\u201343. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305047.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"808_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000508382","volume":"6","author":"TM Aaberg","year":"2020","unstructured":"Aaberg TM, Covington KR, Tsai T, Shildkrot Y, Plasseraud KM, Alsina KM, et al. Gene expression profiling in uveal melanoma: five-year prospective outcomes and meta-analysis. Ocul Oncol Pathol. 2020;6(5):360\u20137. https:\/\/doi.org\/10.1159\/000508382.","journal-title":"Ocul Oncol Pathol"},{"issue":"5","key":"808_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.Ccr-15-2071","volume":"22","author":"MG Field","year":"2016","unstructured":"Field MG, Decatur CL, Kurtenbach S, Gezgin G, van der Velden PA, Jager MJ, et al. PRAME as an independent biomarker for metastasis in uveal melanoma. Clin Cancer Res. 2016;22(5):1234\u201342. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2071.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"808_CR9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1097\/pas.0000000000001134","volume":"42","author":"C Lezcano","year":"2018","unstructured":"Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ. PRAME expression in melanocytic tumors. Am J Surg Pathol. 2018;42(11):1456\u201365. https:\/\/doi.org\/10.1097\/pas.0000000000001134.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"808_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.oraloncology.2012.08.005","volume":"49","author":"MJ Szczepanski","year":"2013","unstructured":"Szczepanski MJ, DeLeo AB, \u0141uczak M, Molinska-Glura M, Misiak J, Szarzynska B, et al. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions. Oral Oncol. 2013;49(2):144\u201351. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.08.005.","journal-title":"Oral Oncol"},{"key":"808_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.lungcan.2016.09.006","volume":"101","author":"S Thongprasert","year":"2016","unstructured":"Thongprasert S, Yang PC, Lee JS, Soo R, Gruselle O, Myo A, et al. The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients. Lung Cancer. 2016;101:137\u201344. https:\/\/doi.org\/10.1016\/j.lungcan.2016.09.006.","journal-title":"Lung Cancer"},{"issue":"3","key":"808_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.bjc.6604494","volume":"99","author":"MT Epping","year":"2008","unstructured":"Epping MT, Hart AA, Glas AM, Krijgsman O, Bernards R. PRAME expression and clinical outcome of breast cancer. Br J Cancer. 2008;99(3):398\u2013403. https:\/\/doi.org\/10.1038\/sj.bjc.6604494.","journal-title":"Br J Cancer"},{"issue":"4","key":"808_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/pas.0000000000001393","volume":"44","author":"C Lezcano","year":"2020","unstructured":"Lezcano C, Pulitzer M, Moy AP, Hollmann TJ, Jungbluth AA, Busam KJ. Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma. Am J Surg Pathol. 2020;44(4):503\u20138. https:\/\/doi.org\/10.1097\/pas.0000000000001393.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"808_CR14","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41379-019-0335-4","volume":"32","author":"A Toyama","year":"2019","unstructured":"Toyama A, Siegel L, Nelson AC, Najmuddin M, Bu L, LaRue R, et al. Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas. Mod Pathol. 2019;32(12):1727\u201333. https:\/\/doi.org\/10.1038\/s41379-019-0335-4.","journal-title":"Mod Pathol"},{"issue":"7","key":"808_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/cup.13958","volume":"48","author":"ME Lohman","year":"2021","unstructured":"Lohman ME, Steen AJ, Grekin RC, North JP. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi. J Cutan Pathol. 2021;48(7):856\u201362. https:\/\/doi.org\/10.1111\/cup.13958.","journal-title":"J Cutan Pathol"},{"key":"808_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.02.031","author":"S Coupland","year":"2022","unstructured":"Coupland S, Kalirai H, Taktak A, Eleuteri A, Damato B. Re: Gelmi et al adding the cancer genome atlas chromosome classes to American Joint Committee on Cancer System offers more precise prognostication in uveal melanoma. Ophthalmology. 2022. https:\/\/doi.org\/10.1016\/j.ophtha.2022.02.031.","journal-title":"Ophthalmology"},{"key":"808_CR17","doi-asserted-by":"publisher","unstructured":"Kapoor AG, Kaliki S, Vempuluru VS, Jajapuram SD, Ali MH, Mohamed A. (2020) Posterior uveal melanoma in 321 Asian Indian patients: analysis based on the 8th edition of American Joint Committee Cancer classification. Int Ophthalmol. 40(11): 3087-3096 https:\/\/doi.org\/10.1007\/s10792-020-01494-2","DOI":"10.1007\/s10792-020-01494-2"},{"key":"808_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2019.151432","volume":"44","author":"J Jha","year":"2020","unstructured":"Jha J, Singh MK, Singh L, Pushker N, Bajaj MS, Sen S, et al. Expression of BAP1 and ATM proteins: association with AJCC tumor category in uveal melanoma. Ann Diagn Pathol. 2020;44: 151432. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151432.","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"808_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000524051","volume":"8","author":"SS Ahmadian","year":"2022","unstructured":"Ahmadian SS, Dryden IJ, Naranjo A, Toland A, Cayrol RA, Born DE, et al. Preferentially expressed antigen in melanoma immunohistochemistry labeling in uveal melanomas. Ocul Oncol Pathol. 2022;8(2):133\u201340. https:\/\/doi.org\/10.1159\/000524051.","journal-title":"Ocul Oncol Pathol"},{"issue":"2","key":"808_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000502550","volume":"6","author":"TR See","year":"2020","unstructured":"See TR, St\u00e5lhammar G, Phillips S, Grossniklaus HE. BAP1 immunoreactivity correlates with gene expression class in uveal melanoma. Ocul Oncol Pathol. 2020;6(2):129\u201337. https:\/\/doi.org\/10.1159\/000502550.","journal-title":"Ocul Oncol Pathol"},{"issue":"8","key":"808_CR21","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2174\/0929867326666190704141444","volume":"27","author":"S Ka\u0161telan","year":"2020","unstructured":"Ka\u0161telan S, Antunica AG, Oreskovi\u0107 LB, Pel\u010di\u0107 G, Kasun E, Hat K. Immunotherapy for uveal melanoma - current knowledge and perspectives. Curr Med Chem. 2020;27(8):1350\u201366. https:\/\/doi.org\/10.2174\/0929867326666190704141444.","journal-title":"Curr Med Chem"},{"issue":"7","key":"808_CR22","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00417-019-04335-w","volume":"257","author":"AC Schefler","year":"2019","unstructured":"Schefler AC, Koca E, Bernicker EH, Correa ZM. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1541\u20135. https:\/\/doi.org\/10.1007\/s00417-019-04335-w.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"808_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajo.2018.07.045","volume":"195","author":"L Cai","year":"2018","unstructured":"Cai L, Paez-Escamilla M, Walter SD, Tarlan B, Decatur CL, Perez BM, et al. Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma. Am J Ophthalmol. 2018;195:154\u201360. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.045.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"808_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s1074-7613(00)80426-4","volume":"6","author":"H Ikeda","year":"1997","unstructured":"Ikeda H, Leth\u00e9 B, Lehmann F, van Baren N, Baurain JF, de Smet C, et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 1997;6(2):199\u2013208. https:\/\/doi.org\/10.1016\/s1074-7613(00)80426-4.","journal-title":"Immunity"},{"issue":"7","key":"808_CR25","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1172\/jci92335","volume":"127","author":"AY Chang","year":"2017","unstructured":"Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide\/HLA-I antigens. J Clin Invest. 2017;127(7):2705\u201318. https:\/\/doi.org\/10.1172\/jci92335.","journal-title":"J Clin Invest"},{"key":"808_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1476-4598-9-226","volume":"9","author":"F Wadelin","year":"2010","unstructured":"Wadelin F, Fulton J, McEwan PA, Spriggs KA, Emsley J, Heery DM. Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia. Mol Cancer. 2010;9:226. https:\/\/doi.org\/10.1186\/1476-4598-9-226.","journal-title":"Mol Cancer"},{"issue":"6","key":"808_CR27","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1245\/s10434-019-07985-6","volume":"27","author":"H Baba","year":"2020","unstructured":"Baba H, Kanda M, Sawaki K, Umeda S, Miwa T, Shimizu D, et al. PRAME as a potential biomarker for liver metastasis of gastric cancer. Ann Surg Oncol. 2020;27(6):2071\u201380. https:\/\/doi.org\/10.1245\/s10434-019-07985-6.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"808_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3969\/j.issn.2095-3941.2012.01.013","volume":"9","author":"K Ding","year":"2012","unstructured":"Ding K, Wang XM, Fu R, Ruan EB, Liu H, Shao ZH. PRAME gene expression in acute leukemia and its clinical significance. Cancer Biol Med. 2012;9(1):73\u20136. https:\/\/doi.org\/10.3969\/j.issn.2095-3941.2012.01.013.","journal-title":"Cancer Biol Med"},{"issue":"3","key":"808_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/genes13030545","volume":"13","author":"G Cazzato","year":"2022","unstructured":"Cazzato G, Mangialardi K, Falcicchio G, Colagrande A, Ingravallo G, Arezzo F, et al. Preferentially expressed antigen in melanoma (PRAME) and human malignant melanoma: a retrospective study. Genes. 2022;13(3):545. https:\/\/doi.org\/10.3390\/genes13030545.","journal-title":"Genes"},{"key":"808_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.leukres.2016.11.005","volume":"52","author":"YH Zhang","year":"2017","unstructured":"Zhang YH, Lu AD, Yang L, Li LD, Chen WM, Long LY, et al. PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy. Leuk Res. 2017;52:43\u20139. https:\/\/doi.org\/10.1016\/j.leukres.2016.11.005.","journal-title":"Leuk Res"},{"issue":"1","key":"808_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-018-1757-3","volume":"17","author":"G Al-Khadairi","year":"2019","unstructured":"Al-Khadairi G, Naik A, Thomas R, Al-Sulaiti B, Rizly S, Decock J. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer. J Transl Med. 2019;17(1):9. https:\/\/doi.org\/10.1186\/s12967-018-1757-3.","journal-title":"J Transl Med"},{"issue":"37","key":"808_CR32","doi-asserted-by":"publisher","first-page":"59209","DOI":"10.18632\/oncotarget.10962","volume":"7","author":"MG Field","year":"2016","unstructured":"Field MG, Durante MA, Decatur CL, Tarlan B, Oelschlager KM, Stone JF, et al. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas. Oncotarget. 2016;7(37):59209\u201319. https:\/\/doi.org\/10.18632\/oncotarget.10962.","journal-title":"Oncotarget"},{"issue":"5\u20136","key":"808_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1159\/000334576","volume":"4","author":"IH Bronkhorst","year":"2012","unstructured":"Bronkhorst IH, Jager MJ. Uveal melanoma: the inflammatory microenvironment. J Innate Immun. 2012;4(5\u20136):454\u201362. https:\/\/doi.org\/10.1159\/000334576.","journal-title":"J Innate Immun"},{"issue":"1","key":"808_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-011-9270-7","volume":"30","author":"B Mlecnik","year":"2011","unstructured":"Mlecnik B, Bindea G, Pag\u00e8s F, Galon J. Tumor immunosurveillance in human cancers. Cancer Metastasis Rev. 2011;30(1):5\u201312. https:\/\/doi.org\/10.1007\/s10555-011-9270-7.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"808_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tranon.2016.10.005","volume":"10","author":"Q Xu","year":"2017","unstructured":"Xu Q, Wang C, Yuan X, Feng Z, Han Z. Prognostic value of tumor-infiltrating lymphocytes for patients with head and neck squamous cell carcinoma. Transl Oncol. 2017;10(1):10\u20136. https:\/\/doi.org\/10.1016\/j.tranon.2016.10.005.","journal-title":"Transl Oncol"},{"issue":"3","key":"808_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1464-410X.2008.08151.x","volume":"103","author":"JF Li","year":"2009","unstructured":"Li JF, Chu YW, Wang GM, Zhu TY, Rong RM, Hou J, et al. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma. BJU Int. 2009;103(3):399\u2013405. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08151.x.","journal-title":"BJU Int"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-022-00808-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-022-00808-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-022-00808-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:21:47Z","timestamp":1672842107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-022-00808-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s13577-022-00808-z","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.<b>Ethical approval<\/b>Ethical approval was obtained from the Institute\u2019s Ethical Committee, All India Institute of Medical Sciences (Ref. No. IEC-189\/05\u201304-2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all the patients before participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}